Heart Failure News and Research RSS Feed - Heart Failure News and Research

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Patient with mechanical heart pump receives new gene therapy for heart failure

Patient with mechanical heart pump receives new gene therapy for heart failure

For the first time in the world, a patient with a mechanical heart pump has received a new gene therapy for heart failure at Harefield Hospital, London. [More]
Black and Hispanic SLE patients are more likely to be readmitted than white patients

Black and Hispanic SLE patients are more likely to be readmitted than white patients

A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. [More]
Researchers discover cardiac molecule that could provide key to treating, preventing heart failure

Researchers discover cardiac molecule that could provide key to treating, preventing heart failure

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure. [More]
Inadequate management common in young-onset Type 2 diabetes

Inadequate management common in young-onset Type 2 diabetes

Patients with young-onset Type 2 diabetes have worse metabolic control than those with late-onset disease, but they are less likely to receive organ-protective drugs, show data from the Joint Asia Diabetes Evaluation cohort. [More]
New Cardio-Oncology Program to keep hearts beating strong throughout breast cancer treatments

New Cardio-Oncology Program to keep hearts beating strong throughout breast cancer treatments

Hearts are at risk when fighting against breast cancer - due to toxic side effects of common treatments like chemotherapy and radiation therapy. [More]
Pay-for-performance schemes only reduce patient death rates in the short term, finds new research

Pay-for-performance schemes only reduce patient death rates in the short term, finds new research

Pay-for-performance schemes - which reward hospitals financially for improving the quality of care provided to patients - only reduce patient death rates in the short term, according to new research by The University of Manchester. [More]
UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

UMass Amherst researcher receives grant to uncover molecular mechanisms of skeletal muscle fatigue

Muscle physiologist Edward Debold at the University of Massachusetts Amherst's School of Public Health and Health Sciences recently received a three-year, $198,000 grant from the American Heart Association to support studies to uncover the molecular mechanisms of skeletal muscle fatigue. [More]
SynCardia temporary Total Artificial Heart with SynHall valves receives FDA approval

SynCardia temporary Total Artificial Heart with SynHall valves receives FDA approval

SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administration for the SynCardia temporary Total Artificial Heart with SynHall valves, giving the company control over the last key component to manufacture the Total Artificial Heart. [More]
Frontiers launches Frontiers in Cardiovascular Medicine journal

Frontiers launches Frontiers in Cardiovascular Medicine journal

Swiss open-access publisher Frontiers, part of the Nature Publishing Group family, is pleased to announce the launch of Frontiers in Cardiovascular Medicine, a new open-access medical journal. [More]
Hypertension control may ward off renal damage in diabetics

Hypertension control may ward off renal damage in diabetics

Elevated blood pressure is associated with an increased risk of renal damage in patients with Type 2 diabetes, especially if they have poor glycaemic control, study findings suggest. [More]
Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS). [More]
Diabetes linked to increased head and neck cancer risk

Diabetes linked to increased head and neck cancer risk

People with diabetes mellitus have a significantly increased risk of developing head and neck cancer compared with those without the condition, show results of a large study conducted in Taiwan. [More]
Salt poses cardiovascular risk in diabetic patients

Salt poses cardiovascular risk in diabetic patients

A diet high in salt increases the risk of cardiovascular disease in patients with Type 2 diabetes, show data from the Japan Diabetes Complications Study. [More]
Religious fasts feasible for diabetic children

Religious fasts feasible for diabetic children

Children with Type 1 diabetes can successfully participate in religious fasts, a study suggests. [More]
Household income plays key role in avoidable hospital visits across New Jersey

Household income plays key role in avoidable hospital visits across New Jersey

The household income of its residents is the most important factor in whether a community has high or low rates of avoidable hospital visits - conditions that could be better managed in a doctor's office or other health care settings if treated at an early stage, according to a report released today by the Rutgers Center for State Health Policy (CSHP). [More]
Catheter ablation improves quality of life for adults with atrial fibrillation

Catheter ablation improves quality of life for adults with atrial fibrillation

Adults who undergo a minimally invasive technique to treat atrial fibrillation are significantly less likely to die from a heart attack or heart failure, according to a long-term study by the University of Michigan Frankel Cardiovascular Center. [More]
Researchers examine impact of extreme temperatures on number of deaths

Researchers examine impact of extreme temperatures on number of deaths

When temperatures are extremely high or low, there is a significant increase in the number of deaths caused by heart failure or stroke. [More]

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers. [More]
Neuregulin 1 effective in promoting peripheral nerve regrowth

Neuregulin 1 effective in promoting peripheral nerve regrowth

Neuregulin 1 (NRG1) is a pleiotropic factor characterized by the existence of numerous isoforms arising from alternative splicing of exons that confer to the protein deeply different characteristics. [More]
Albuminuria change is a strong cardiovascular risk indicator in diabetes

Albuminuria change is a strong cardiovascular risk indicator in diabetes

Changes in albuminuria predict cardiovascular mortality and morbidity over and above glucose levels and blood pressure, say researchers. [More]